{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.Clinicalstudies.in/SOP-for-Subject-Retention-and-Follow-Up”
},
“headline”: “SOP for Subject Retention and Follow-Up in Clinical Trials”,
“description”: “This SOP establishes procedures for subject retention and follow-up in clinical trials, ensuring participant engagement, compliance with trial requirements, and alignment with ICH GCP, FDA, EMA, CDSCO, and WHO regulations.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for Subject Retention and Follow-Up

Purpose

The purpose of this SOP is to outline the procedures for subject retention and follow-up in clinical trials. Retention ensures participants complete the study as planned, enabling reliable data analysis and protecting participant safety while complying with ethical and regulatory standards.

Scope

This SOP applies to investigators, sub-investigators, study coordinators, CRO staff, and sponsors involved in maintaining participant engagement, follow-up visit completion, and documentation of retention efforts throughout the trial.

Responsibilities

• Principal Investigator (PI): Oversees subject retention strategies and ensures compliance with protocol-defined follow-up schedules.
• Study Coordinator: Maintains Retention and Follow-Up Logs, schedules visits, and communicates with participants.
• Sponsor/CRO: Provides resources for retention strategies and reviews site-level retention metrics.
• Investigators: Conduct medical follow-up and document outcomes of retention activities.
• Quality Assurance Officer: Audits retention documentation during monitoring and inspections.

Accountability

The PI is accountable for implementing and monitoring retention strategies, ensuring participants remain engaged, and documenting reasons for withdrawal or loss to follow-up. Sponsors are accountable for monitoring dropout rates and supporting corrective actions.

Procedure

1. Retention Planning
Develop subject retention strategies during trial initiation.
Provide participants with clear schedules and expectations at consent.

2. Communication with Participants
Maintain regular contact through phone calls, emails, and reminder messages.
Provide culturally appropriate and participant-friendly communication.

3. Visit Scheduling and Reminders
Schedule visits in advance and confirm appointments with participants.
Use SMS/email reminders to reduce missed visits.

4. Managing Follow-Up
Conduct follow-up visits as per protocol requirements.
Record all completed and missed visits in the Follow-Up Log (Annexure-1).

5. Addressing Barriers
Identify reasons for missed visits or dropouts (e.g., travel, personal commitments).
Provide support such as transportation reimbursement where permitted.

6. Withdrawal and Loss to Follow-Up
Document reasons for participant withdrawal or loss to follow-up.
Record attempts to contact participants in the Withdrawal/Follow-Up Log (Annexure-2).

7. Archiving
File retention and follow-up documentation in ISF and TMF.
Retain records for at least 5 years post-trial or as required by regulations.

Abbreviations

• SOP: Standard Operating Procedure
• PI: Principal Investigator
• CRO: Clinical Research Organization
• ISF: Investigator Site File
• TMF: Trial Master File
• QA: Quality Assurance

Documents

1. Follow-Up Log (Annexure-1)
2. Retention/Withdrawal Tracking Log (Annexure-2)
3. Subject Communication Record (Annexure-3)

References

• ICH E6(R2) – Good Clinical Practice
• US FDA – Clinical Trial Oversight
• EMA Clinical Trial Regulation
• CDSCO Clinical Trial Rules, 2019
• WHO – Guidelines on Clinical Research Retention

Version: 1.0

Approval Section

Annexures

Annexure-1: Follow-Up Log

Annexure-2: Retention/Withdrawal Tracking Log

Annexure-3: Subject Communication Record

Revision History

For more SOPs visit: Pharma SOP